Encephalomyocarditis virus RNA. III. Presence of a genome-associated protein.

Por Hruby, D E, Roberts, W K
Publicado em 1978

Encephalomyocarditis virus RNA: variations in polyadenylic acid content and biological activity.

Por Hruby, D E, Roberts, W K
Publicado em 1976

Mechanism of Mengo Virus-Induced Cell Injury in L Cells: Use of Inhibitors of Protein Synthesis to Dissociate Virus-Specific Events

Por Collins, F. D., Roberts, W. K.
Publicado em 1972

Encephalomyocarditis virus RNA. II. Polyadenylic acid requirement for efficient translation.

Por Hruby, D E, Roberts, W K
Publicado em 1977

The specific substance from Pneumococcus type 34 (41). The structure of a phosphorus-free repeating unit

Por Roberts, W. K., Buchanan, J. G., Baddiley, J.
Publicado em 1963

2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication.

Por Rice, A P, Roberts, W K, Kerr, I M
Publicado em 1984

Interferon-induced inhibition of protein synthesis in L-cell extracts: an ATP-dependent step in the activation of an inhibitor by double-stranded RNA.

Por Roberts, W K, Clemens, M J, Kerr, I M
Publicado em 1976

Liver Vitamin A Storage in Fattening Cattle Following Intraruminal of Intramuscular Injection of Vitamin A

Por Roberts, W. K., Findlay, G. M., Stringam, E. W.
Publicado em 1965

Macrophage activation: dissociation of cytotoxic activity from Ia-A antigen expression.

Por Blumenthal, E J, Roberts, W K, Vasil, A, Talmage, D W
Publicado em 1983

The specific substance from Pneumococcus type 34 (41). The phosphodiester linkages

Por Chittenden, G. J. F., Roberts, W. K., Buchanan, J. G., Baddiley, J.
Publicado em 1968

Novel 2',5'-oligoadenylates synthesized in interferon-treated, vaccinia virus-infected cells.

Por Rice, A P, Kerr, S M, Roberts, W K, Brown, R E, Kerr, I M
Publicado em 1985